Page 131 - Azerbaijan State University of Economics
P. 131

THE JOURNAL OF ECONOMIC SCIENCES: THEORY AND  PRACTICE, V.71,  # 1, 2014,  pp. 127-139



               pay-per-performance way with the single providers may be an adequate way to overcome this


               shortfall in the care and incentive mechanism. Idea of this paper was to adapt a simulation for an

               approximation on the health economic effects of such a technology in the AR.

                     III. METHODOLOGY OF BUILDING THE MODEL


                     Simulations and Modelling are defined as a “... replicable sequence  of computations used for

               generating estimates  of quantities of  concern  [...]  based on data  from primary and/or secondary

               sources…” [National Reasearch Council. Improving Information for Social Policy Decisisions: the


               Uses of Microsimulation Modeling. Vol 1. Review and Recommandations. National Academy Press,

               Washington DC, 1991] and are recommended in  the  modernization Act of the  Food  and Drug


               Administration (FDA) end of the 80´s[Compare: www.fda.gov/cdrh/modact97.pdf] as valueable tool

               to help in healthcare and social policy decisions. According to the FDA simulations it can also be

               some  kind of “Evidence  based  Medicine”  (EBM) – which names  the conscientious, explicit  and


               judicious use of current best external evidence in makingdecisionsin the care of individual patients

               [Sackett DL, Rosenberg WMC et al.: Evidence-based medicine: What it is and what it isn’t. BMJ,

               1996, 312, 71-72]. This Definition includes, that EBM is not limited to studies and meta-analyzes.


               Also the general  concept of the  expected value of  information  (VOI)  from  decision  theory

               [http://en.wikipedia.org/wiki/Value_of_information] is transferable to EBM:The VOI is defined as

               the difference between the  expected  consequences (benefits) of  a decision to be  made  under


               consideration of specific information and the expected consequences (benefits) if that decision is

               made  without that information  [Raiffa  H.: Decision  Analysis; Introductory Lectures  on Choices

               under Uncertainty.  Reading,  MA.Addison Wesley, 1968].  Due  to  this high expectation several


               standards for testing and validating a healthcare simulation had to be kept [Weinstein MC; O’Brian B

               et al.: Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report




                                                           131
   126   127   128   129   130   131   132   133   134   135   136